People receiving weight-loss drug Wegovy sustained weight loss for up to four years, shedding an average of 10% of their body weight in that time, as per a new study. Wegrovy is a brand that markets semaglutide injections, that have gained widespread attention for their weight-loss effects. The study also found that Semaglutide injections boost an individual's heart health, even when weight loss doesn't take place.

The study, called SELECT, was published in journal Nature Medicine. "At four years, we see ongoing benefits of semaglutide," said Cheng-Han Chen, MD, interventional cardiologist from Cardiologist, who was not involved in the research. Besides the weight loss, it also lead to a loss in cardiovascular outcomes.

The research was conducted on 17000 adults, who had obesity but did not have diabetes. Overall, people who received once-weekly injections of semaglutide lost on average 10.2% of their body weight over the course of four years. All of the study participants continued to lose weight for about 65 weeks, a year and three months, and then their weight remained at a stable level.

Were There Any Side Effects?

What Did The Results Say?

Of the people on the highest dose of Wegovy, 68% lost at least 5% of their body weight. This compared to 21% of people on the placebo. Additionally, of the total people on Wegovy about 23% lost at least 15% of their body weight. For those in the placebo group, only 1.7% lost that much body weight.

Semaglutide Shows Heart Benefits Beyond Weight Loss

Researchers found that even individuals who did not experience significant weight reduction while on the drug saw a reduced risk of major heart events. Recent analysis of the SELECT trial data revealed that semaglutide significantly lowers the risk of heart attack, stroke, and cardiovascular-related deaths in adults with obesity or those who are overweight. Notably, the results of this study lead the US FDA to approve Novo Nordisk's Wegovy for reducing heart-related risks in this group.

What Is Semaglutide?

Are Their Any Side Effects Of Semaglutide?

Semaglutide, marketed under the brand name Wegovy, is primarily an antidiabetic medication used to treat Type 2 diabetes. It is also an anti-obesity drug used for long-term weight management. While it can be taken as a subcutaneous injection or orally, it has significant side effects. It primarily impacts your gastrointestinal tract and its side effects include constipation, nausea, abdominal pain, diarrhoea, and fatigue amongst others.

The manosphere is a network of male-centric online groups, forums and communities that focus on men’s issues, masculinity definition and the changing roles and treatment of men in today’s world. Oftentimes, the content produced in the manosphere leans heavily towards promoting misogyny online, distorting the definitions of feminism and masculinity.

A recent Lancet report highlights this issue, stating that these online communities that promote misogyny, male victimisation and hostility towards feminism are actually a growing public health problem. The report also suggests that this public health concern should be addressed in the same way as obesity or smoking.

The researchers say that the so-called manosphere not only normalises violence and misogyny towards women but also affects men’s mental health, fueling issues like social isolation and discouraging them from seeking help.

In the paper, titled Reframing the manosphere: a public health response to a commercial ecosystem, authors Sarah J Hawkes and Kent Buse describe the manosphere as a “diffuse commercial ecosystem and loose collection of online communities united by shared beliefs about masculinity, misogyny, and male victimisation”.

These communities often promote the idea that men are facing masculinity crisis and social isolation and that feminism has systematically disadvantaged and exploited them. The authors argue that these narratives can wrongfully make young men believe that their personal difficulties are due to women, which could direct their frustration towards the opposite gender.

The authors wrote, “Men’s problems are framed [in the manosphere] as the result of feminism rather than structural conditions, and masculine identity is commodified through products and paid content that normalise and reinforce health-harming and performance-oriented masculinities.”

Manosphere And Men's Mental Health

Also read: Gender-based Violence Surging Global Antimicrobial Resistance, Say Experts

The authors identify several conditions that can make boys and young men vulnerable to manosphere content, including loneliness, educational disengagement, social exclusion, financial insecurity and uncertainty about their future.

Prof Sarah Hawkes, the report’s other author, said, “The manosphere offers boys and young men belonging, identity and an explanation for why life feels hard."

She added, “Those needs are real. A response that only removes the manosphere, without offering something credible in its place, will fail. We need to offer boys something better, not just tell them what to avoid.”

The authors also say that they may also reinforce resentment towards women and promote toxic ideas about masculinity, gender, relationships and success. They also say that these communities can harm men's mental health, contribute to body image concerns and discourage them from seeking professional support.

The authors argue that this business model can exploit insecurity while presenting structural problems as individual failures or the result of feminism. Some influencers promote twisted ideas of masculinity and encourage followers to purchase supplements, hormones and financial products.

Prof Kent Buse, a co-author of the paper and co-founder of the social justice thinktank Global 50/50, explained, “This is a business model, not a fringe. Outrage and grievance are good for business, so the system rewards the most extreme content. Expect the playbook that served tobacco so well: blame the individual, and call regulation an attack on freedom. Public health has a tested toolkit for commercial harms and we should use it.”

Online Misogyny Contributes To Violence Against Women

Also read: 'Put Up with the Pain': UK Report Exposes Gaps in Women's Reproductive Healthcare

The report also examines the consequences of following manosphere for women and girls. The authors warn that the manosphere can normalise misogynistic outlooks, reinforce gender inequality and create an environment in which violence against women and girls is more readily accepted.

The concern is not limited to individual posts or influencers. The researchers describe a commercial network in which content creators can benefit from extreme expressions of gender and hostility.

They compare the strategies used by this online ecosystem with those of industries such as tobacco and ultra-processed food, arguing that both can shift responsibility towards individuals while resisting regulation.

“Outrage and grievance are good for business, so the system rewards the most extreme content,” said co-author Kent Buse.

He added, “Boys and men are not the problem. The problem is the conditions that leave them isolated and without a secure future, and the companies that profit from their anger and insecurity.”

Just Censoring Harmful Content May Not Be Enough

Also read: Amid Changing Health Laws In The US, Would Abortion Become Illegal?

The authors argue that simply removing misogynistic content or restricting access to certain communities will not address the reasons why young men are drawn to them.

Co-author Sarah Hawkes said, “The manosphere offers boys and young men belonging, identity and an explanation for why life feels hard. Those needs are real. A response that only removes the manosphere, without offering something credible in its place, will fail. We need to offer boys something better, not just tell them what to avoid.”

The report also calls for a coordinated response involving governments, schools, healthcare services and community organisations. This includes improving access to education, skills training and employment opportunities, addressing social isolation and ensuring that boys and young men can access mental health services.

Manosphere Is A Public Health Issue

The researchers identify six priorities for action: addressing the social and economic conditions that make young men vulnerable, improving collaboration between health and education services, developing effective communication strategies, regulating harmful platforms, investing in research and monitoring, and confronting the bigger misogyny and anti-gender equality attitudes that keeps these communities running.

They argue that regulation should focus on the commercial incentives that amplify harmful content, rather than placing the entire responsibility on individuals who consume it.

Menopause is gradually finding its well-deserved place in mainstream media. For the first time in a dozen years, the American College of Obstetricians and Gynecologists (ACOG) has revised its clinical guidance on treating key menopause symptoms like including hot flashes, night sweats, sleep disturbances and mood swings.

The new guidance, released in October 2026, talks about hormone therapy as the most effective treatment for moderate to severe hot flashes.

It also highlights non-hormonal options like cognitive behavioural therapy, mindfulness and clinical hypnosis for women who do not want to opt for hormone therapy.

The update comes after certain boxed safety warnings on hormone-based products were removed by the US Food and Drug Administration (FDA).

Hormone Therapy Recommended For Women With Menopause

Also read: Beyond “Just Ageing”: Why Menopause Deserves a Place in India’s Mainstream Healthcare Conversation

Menopausal hormone therapy (MHT) is the most effective treatment for vasomotor symptoms, which include hot flashes and night sweats. These symptoms occur as changing hormone levels affect the body's temperature.

ACOG recommends systemic hormone therapy containing oestrogen and a progestogen for women with a uterus. Women who do not need endometrial protection may receive oestrogen alone.

The guidance also suggests considering hormone therapy for sleep disturbances, which is also one of the vasomotor symptoms.

However, hormone therapy may not be a viable option for everyone. Decisions should be made jointly by patients and their doctors, which may be taken after taking into account age, medical history, cardiovascular disease risk, breast cancer risk and the risk of venous thromboembolism, or blood clots.

ACOG also recommends starting treatment before the age of 60 or within 10 years of the onset of natural menopause for.

Women Who Cannot Take Hormone Therapy

Also read: Perimenopause & Cardiovascular Health: Why Neglecting Heart Warning Signs During Perimenopause Can Lead to Heart Issues

Women who cannot take hormone therapy have several other non-hormonal options. ACOG recommends selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), which are antidepressant medicines that can also help manage hot flashes.

Another option is neurokinin receptor antagonists. These medicines act on pathways involved in regulating body temperature and can reduce hot flashes and night sweats. Fezolinetant and elinzanetant are examples of medicines in this category.

Gabapentin may also be considered when other non-hormonal medicines are ineffective .

Lifestyle And Behavioural Changes

The updated guidance also recognises lifestyle and behavioural changes for managing menopause symptoms. ACOG suggests cognitive behavioural therapy (CBT) to help with hot flashes, sleep disturbances and mood symptoms.

Mindfulness-based interventions and physical exercise may help improve sleep and mood, while clinical hypnosis may reduce hot flashes and improve sleep and anxiety symptoms.

Acupuncture is also an option that may help tackle vasomotor symptoms and improve sleep and mood.

These alternative options can be used alone or alongside medication, depending on a woman's symptoms and treatment preferences.

Menopause can affect several aspects of health and daily life. Hot flashes and night sweats can disrupt sleep, while mood changes and other symptoms may affect work, relationships and overall quality of life.

For a long time, concerns about the risks of hormone therapy have influenced how patients and doctors approach treatment.

The new guidance reinforces that hormone therapy remains an effective option for many women, while stressing the importance of individual risk assessment and preference.

When we think of perimenopause, irregular periods, hot flashes and mood changes usually come to mind. But the transition to menopause is not limited to the menstrual cycle. Behind the scenes, changing ovarian hormones—particularly fluctuating and eventually declining estrogen—can influence body composition, insulin sensitivity, cholesterol levels, bone health and cardiovascular risk.

For many women, these metabolic changes begin years before their final menstrual period.

Why does weight suddenly behave differently?

A common concern during perimenopause is: “I haven’t changed my diet, so why am I gaining weight around my abdomen?”

Ageing itself contributes to gradual loss of muscle mass and changes in energy expenditure. At the same time, the menopausal transition is associated with a shift in fat distribution, with a greater tendency to accumulate visceral or abdominal fat.

This matters because visceral fat is metabolically active. An increase in abdominal fat can be associated with insulin resistance, abnormal cholesterol levels and a higher risk of metabolic disease. So, the change in waist circumference may sometimes tell us more about metabolic health than the number on the weighing scale alone.

Also read: After Menopause, These Breast Changes Shouldn’t Be Ignored

Blood sugars may raise up too

Estrogen interacts with several pathways involved in glucose and fat metabolism. During midlife, changes in body composition, reduced physical activity, sleep disturbance and hormonal changes can collectively make insulin sensitivity less favourable.

This does not mean every woman going through perimenopause will develop diabetes. However, women who already have risk factors—such as overweight or obesity, prediabetes, a history of gestational diabetes or a strong family history of type 2 diabetes—should be particularly mindful.

Cholesterol and heart health deserve attention

The menopausal transition can also be accompanied by unfavourable changes in the lipid profile, including changes in LDL cholesterol. Cardiovascular risk increases with age, and menopause is an important time to reassess risk factors such as blood pressure, glucose, cholesterol, smoking, physical activity and body composition.

Women often spend years focusing on reproductive health while overlooking these equally important metabolic markers.

Also read: World Menopause Day: Is It Empty Nest Syndrome Or Menopause Symptoms? Expert Explains

Muscles and bones need attention as well

Midlife is also an important period for protecting muscle and bone. Declining estrogen after menopause accelerates bone loss, while ageing contributes to loss of muscle mass.

Resistance training therefore becomes especially valuable. Adequate protein intake, regular weight-bearing exercise, sufficient calcium and vitamin D, good sleep and avoiding smoking can support healthier ageing.

What should women do?

Perimenopause should not be viewed as a disease, nor should every symptom or kilogram gained in midlife automatically be blamed on hormones. Instead, it is an opportunity for a metabolic health check.

Women should discuss appropriate screening for blood pressure, blood glucose or HbA1c, lipid profile, weight and waist circumference monitoring , DEXA scan for bone health, depending on their individual risk factors.

Most importantly, don’t wait for menopause to start thinking about metabolic health. The perimenopausal years can be an important window to build muscle, improve fitness, optimise nutrition and identify metabolic risk early.

Perimenopause is more than a change in periods—it is a transition in whole-body health. Understanding these changes early can help women enter the next phase of life stronger, healthier and better prepared.

(By Dr. Seema Daksh, MBBS, MD (Internal Medicine), DM (Endocrinology), Consultant Endocrinologist,Kailash Hospital, Greater Noida)